{"submission_count":"2","variation_id":"37594","date_last_evaluated":"2018-05-24","interpretation":"Conflicting interpretations of pathogenicity","version":"2","trait_set_id":"13598","id":"RCV000219296","variation_archive_id":"VCV000037594","review_status":"criteria provided, conflicting interpretations","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Hereditary cancer-predisposing syndrome"}
{"submission_count":"4","variation_id":"822","date_last_evaluated":"2019-02-28","interpretation":"Pathogenic/Likely pathogenic, risk factor","version":"12","trait_set_id":"13598","id":"RCV000115087","variation_archive_id":"VCV000000822","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Hereditary cancer-predisposing syndrome"}
{"submission_count":"2","variation_id":"17674","date_last_evaluated":"2019-03-26","interpretation":"Pathogenic","version":"6","trait_set_id":"13598","id":"RCV000131887","variation_archive_id":"VCV000017674","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Hereditary cancer-predisposing syndrome"}
{"submission_count":"1","variation_id":"481015","interpretation":"not provided","version":"1","trait_set_id":"9460","id":"RCV000786847","variation_archive_id":"VCV000481015","review_status":"no assertion provided","title":"NM_001126112.2(TP53):c.375+5G\u003eA AND not provided"}
{"submission_count":"1","variation_id":"481015","date_last_evaluated":"2016-05-16","interpretation":"Uncertain significance","version":"1","trait_set_id":"13598","id":"RCV000567707","variation_archive_id":"VCV000481015","review_status":"criteria provided, single submitter","title":"NM_001126112.2(TP53):c.375+5G\u003eA AND Hereditary cancer-predisposing syndrome"}
{"submission_count":"1","variation_id":"481015","date_last_evaluated":"2018-12-01","interpretation":"Likely pathogenic","version":"1","trait_set_id":"35155","id":"RCV000785337","variation_archive_id":"VCV000481015","review_status":"no assertion criteria provided","title":"NM_001126112.2(TP53):c.375+5G\u003eA AND Ovarian Neoplasms"}
{"submission_count":"2","variation_id":"42540","date_last_evaluated":"2018-06-18","interpretation":"Pathogenic","version":"2","trait_set_id":"32616","id":"RCV000252398","variation_archive_id":"VCV000042540","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_000256.3(MYBPC3):c.1504C\u003eT (p.Arg502Trp) AND Cardiovascular phenotype"}
{"submission_count":"2","variation_id":"42540","date_last_evaluated":"2019-12-30","interpretation":"Pathogenic","version":"4","trait_set_id":"2365","id":"RCV000677196","variation_archive_id":"VCV000042540","review_status":"criteria provided, multiple submitters, no conflicts","title":"NM_000256.3(MYBPC3):c.1504C\u003eT (p.Arg502Trp) AND Familial hypertrophic cardiomyopathy 4"}
